Therapeutic rescue of mice treated with a lethal dose of acetaminophen

Sudip Banerjee,John R Latendresse,Harihara M Mehendale
DOI: https://doi.org/10.1096/fasebj.25.1_supplement.1018.5
2011-04-01
The FASEB Journal
Abstract:Earlier studies (Bhave et al., Toxicol. Appl. Pharmacol., 228: 225–238, 2008) revealed that secretory phospholipaseA2 (sPLA2) is a death protein that mediates progression of injury initiated by hepatotoxicants such as acetaminophen (APAP), CCl4, and thioacetamide. The objective of present work was to inhibit sPLA2 at 1 h after liver injury was initiated by a lethal dose (600 mg/kg, i.p. in 0.45N NaCl2) of APAP administered to male Swiss Webster mice. Survival and mortality were recorded every 12 hours for 14 days. Mortalities were 50%, and 80% at 12 and 24h, respectively, after APAP injection. No mortality occurred in mice receiving the sPLA2 inhibitor (sPLA2inh) until 72h. At 14 days, cumulative mortality was only 10 % in the sPLA2inh group. Serum ALT and sPLA2 activities revealed very high liver necrosis and continued progression of liver injury in mice treated with APAP alone, while decreasing in mice receiving the sPLA2inh. These findings confirm the destructive role of sPLA2 by mediating the progression of liver injury. Our findings also reveal that it is possible to develop lifesaving therapeutic intervention administered well after the exposure to lethal overdose of APAP. Supported by Kitty Degree Endowment.
cell biology,biochemistry & molecular biology,biology
What problem does this paper attempt to address?